Characterization of monocyte chemoattractant proteins and CC chemokine receptor 2 expression during atherogenesis in apolipoprotein E-null mice

Journal of Atherosclerosis and Thrombosis

Volumn 18, Issue 10, 2011, Pages 846-856

  Zhang, Shun ^a   Wang, Xu ^a   Zhang, Liang ^a   Yang, Xiaolei ^a   Pan, Jie ^a   Ren, Guocheng ^a  

^a SHANDONG NORMAL UNIVERSITY   (China)

Author keywords

Activator protein 1; Apolipoprotein E null mice; Atherosclerosis; CC chemokine receptor 2; Monocyte chemoattractant proteins; Nuclear factor B

Indexed keywords

APOLIPOPROTEIN E; CHEMOKINE RECEPTOR CCR2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; PROTEIN C FOS; PROTEIN C JUN; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR AP 1;

ANIMAL EXPERIMENT; AORTA; ARTICLE; ATHEROGENESIS; BLOOD CELL; CELLULAR DISTRIBUTION; CHOLESTEROL DIET; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID DIET; MACROPHAGE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE CELL;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BASE SEQUENCE; DNA PRIMERS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTE CHEMOATTRACTANT PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CCR2;

EID: 80055111261     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.7211     Document Type: Article

References (52)

1. Ross R: Atherosclerosis--an inflammatory disease. N Engl J Med, 1999; 340: 115-126
2. Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med, 2005; 352: 1685-1695
3. Libby P: Inflammation in atherosclerosis. Nature, 2002; 420: 868-874
4. Glass CK, Witztum JL: Atherosclerosis. the road ahead. Cell, 2001; 104: 503-516
5. Hansson GK, Jonasson L, Seifert PS, Stemme S: Immune mechanisms in atherosclerosis. Arteriosclerosis, 1989; 9: 567-578
6. Charo IF, Ransohoff RM: The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med, 2006; 354: 610-621
7. Wang JM, Su S, Gong W, Oppenheim JJ: Chemokines, receptors, and their role in cardiovascular pathology. Int J Clin Lab Res, 1998; 28: 83-90
8. Murphy PM: Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev, 1996; 7: 47-64
9. Horuk R: Molecular properties of the chemokine receptor family. Trends Pharmacol Sci, 1994; 15: 159-165
10. Uguccioni M, D' Apuzzo M, Loetscher M, Dewald B, Baggiolini M: Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes. Eur J Immunol, 1995; 25: 64-68
11. Rabin RL, Park MK, Liao F, Swofford R, Stephany D, Farber JM: Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling. J Immunol, 1999; 162: 3840-3850
12. Loetscher P, Seitz M, Clark-Lewis I, Baggiolini M, Moser B: Activation of NK cells by CC chemokines. Chemotaxis, Ca2+ mobilization, and enzyme release. J Immunol, 1996; 156: 322-327
13. Reape TJ, Groot PH: Chemokines and atherosclerosis. Atherosclerosis, 1999; 147: 213-225
14. Rossi D, Zlotnik A: The biology of chemokines and their receptors. Annu Rev Immunol, 2000; 18: 217-242
15. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation, 2002; 105: 1135-1143
16. Boring L, Gosling J, Cleary M, Charo IF: Decreased lesion formation in CCR2?/?mice reveals a role for chemokines in the initiation of atherosclerosis. Nature, 1998; 394: 894-897
17. Dawson TC, Kuziel WA, Osahar TA, Maeda N: Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis, 1999; 143: 205-211
18. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ: Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell, 1998; 2: 275-281
19. Ping D, Boekhoudt GH, Rogers EM, Boss JM: Nuclear factor-kappa B p65 mediates the assembly and activation of the TNF-responsive element of the murine monocyte chemoattractant-1 gene. J Immunol, 1999; 162: 727-734
20. Chen YM, Chiang WC, Lin SL, Wu KD, Tsai TJ, Hsieh BS: Dual regulation of tumor necrosis factor-alpha-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-kappaB and activator protein-1: modulation by type III phosphodiesterase inhibition. J Pharmacol Exp Ther, 2004; 309: 978-986
21. Martin T, Cardarelli PM, Parry GC, Felts KA, Cobb RR: Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1. Eur J Immunol, 1997; 27: 1091-1097
22. Tsou CL, Peters W, Si Y, Slaymaker S, Aslanian AM, Weisberg SP, Mack M, Charo IF: Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest, 2007; 117: 902-909
23. Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, Kleinman HK, Oppenheim JJ, Murphy WJ: Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood, 2000; 96: 34-40
24. Weber KS, Nelson PJ, Grone HJ, Weber C: Expression of CCR2 by endothelial cells: implications for MCP-1 mediated wound injury repair and In vivo inflammatory activation of endothelium. Arterioscler Thromb Vasc Biol, 1999; 19: 2085-2093
25. Hayes IM, Jordan NJ, Towers S, Smith G, Paterson JR, Earnshaw JJ, Roach AG, Westwick J, Williams RJ: Human vascular smooth muscle cells express receptors for CC chemokines. Arterioscler Thromb Vasc Biol, 1998; 18: 397-403
26. Denger S, Jahn L, Wende P, Watson L, Gerber SH, Kubler W, Kreuzer J: Expression of monocyte chemoattractant protein-1 cDNA in vascular smooth muscle cells: induction of the synthetic phenotype: a possible clue to SMC differentiation in the process of atherogenesis. Atherosclerosis, 1999; 144: 15-23
27. Spinetti G, Wang M, Monticone R, Zhang J, Zhao D, Lakatta EG: Rat aortic MCP-1 and its receptor CCR2 increase with age and alter vascular smooth muscle cell function. Arterioscler Thromb Vasc Biol, 2004; 24: 1397-1402
28. Ikeda U, Ikeda M, Seino Y, Takahashi M, Kasahara T, Kano S, Shimada K: Expression of intercellular adhesion molecule-1 on rat vascular smooth muscle cells by pro-inflammatory cytokines. Atherosclerosis, 1993; 104: 61-68
29. Zhang L, Geng Y, Yin M, Mao L, Zhang S, Pan J: Low omega-6/omega-3 polyunsaturated fatty acid ratios reduce hepatic C-reactive protein expression in apolipoprotein E-null mice. Nutrition, 26: 829-834
30. Yla-Herttuala S, Lipton BA, Rosenfeld ME, Sarkioja T, Yoshimura T, Leonard EJ, Witztum JL, Steinberg D: Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A, 1991; 88: 5252-5256
31. Nelken NA, Coughlin SR, Gordon D, Wilcox JN: Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest, 1991; 88: 1121-1127
32. Yu X, Dluz S, Graves DT, Zhang L, Antoniades HN, Hollander W, Prusty S, Valente AJ, Schwartz CJ, Sonenshein GE: Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates. Proc Natl Acad Sci U S A, 1992; 89: 6953-6957
33. Rayner K, Van Eersel S, Groot PH, Reape TJ: Localisation of mRNA for JE/MCP-1 and its receptor CCR2 in atherosclerotic lesions of the ApoE knockout mouse. J Vasc Res, 2000; 37: 93-102
34. Dol F, Martin G, Staels B, Mares AM, Cazaubon C, Nisato D, Bidouard JP, Janiak P, Schaeffer P, Herbert JM: Angiotensin AT1 receptor antagonist irbesartan decreases lesion size, chemokine expression, and macrophage accumulation in apolipoprotein E-deficient mice. J Cardiovasc Pharmacol, 2001; 38: 395-405
35. Zhou X, Paulsson G, Stemme S, Hansson GK: Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J Clin Invest, 1998; 101: 1717-1725
36. Zhou X, Johnston TP, Johansson D, Parini P, Funa K, Svensson J, Hansson GK: Hypercholesterolemia leads to elevated TGF-beta1 activity and T helper 3-dependent autoimmune responses in atherosclerotic mice. Atherosclerosis, 2009; 204: 381-387
37. Schober A, Zernecke A, Liehn EA, von Hundelshausen P, Knarren S, Kuziel WA, Weber C: Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets. Circ Res, 2004; 95: 1125-1133
38. Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ, Fogelman AM: Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A, 1990; 87: 5134-5138
39. Ueda A, Ishigatsubo Y, Okubo T, Yoshimura T: Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-kappaB sites and NF-kappaB/Rel subunit specificity. J Biol Chem, 1997; 272: 31092-31099
40. Shyy JY, Lin MC, Han J, Lu Y, Petrime M, Chien S: The cis-acting phorbol ester "12-O-tetradecanoylphorbol 13-acetate" -responsive element is involved in shear stress-induced monocyte chemotactic protein 1 gene expression. Proc Natl Acad Sci U S A, 1995; 92: 8069-8073
41. Hattori Y, Matsumura M, Kasai K: Vascular smooth muscle cell activation by C-reactive protein. Cardiovasc Res, 2003; 58: 186-195
42. Han KH, Tangirala RK, Green SR, Quehenberger O: Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL. Arterioscler Thromb Vasc Biol, 1998; 18: 1983-1991
43. Tangirala RK, Murao K, Quehenberger O: Regulation of expression of the human monocyte chemotactic protein-1 receptor (hCCR2) by cytokines. J Biol Chem, 1997; 272: 8050-8056
44. Wong LM, Myers SJ, Tsou CL, Gosling J, Arai H, Charo IF: Organization and differential expression of the human monocyte chemoattractant protein 1 receptor gene. Evidence for the role of the carboxyl-terminal tail in receptor trafficking. J Biol Chem, 1997; 272: 1038-1045
45. Schecter AD, Berman AB, Yi L, Ma H, Daly CM, Soejima K, Rollins BJ, Charo IF, Taubman MB: MCP-1dependent signaling in CCR2(?/?) aortic smooth muscle cells. J Leukoc Biol, 2004; 75: 1079-1085
46. Gong X, Gong W, Kuhns DB, Ben-Baruch A, Howard OM, Wang JM: Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors. J Biol Chem, 1997; 272: 11682-11685
47. Taub DD, Proost P, Murphy WJ, Anver M, Longo DL, van Damme J, Oppenheim JJ: Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest, 1995; 95: 1370-1376
48. Ruffing N, Sullivan N, Sharmeen L, Sodroski J, Wu L: CCR5 has an expanded ligand-binding repertoire and is the primary receptor used by MCP-2 on activated T cells. Cell Immunol, 1998; 189: 160-168
49. Weber M, Uguccioni M, Ochensberger B, Baggiolini M, Clark-Lewis I, Dahinden CA: Monocyte chemotactic protein MCP-2 activates human basophil and eosinophil leukocytes similar to MCP-3. J Immunol, 1995; 154: 4166-4172
50. Tone A, Shikata K, Ogawa D, Sasaki S, Nagase R, Sasaki M, Yozai K, Usui HK, Okada S, Wada J, Shikata Y, Makino H: Changes of gene expression profiles in macrophages stimulated by angiotensin II--angiotensin II induces MCP-2 through AT1-receptor. J Renin Angiotensin Aldosterone Syst, 2007; 8: 45-50
51. Wang X, Li X, Yue TL, Ohlstein EH: Expression of monocyte chemotactic protein-3 mRNA in rat vascular smooth muscle cells and in carotid artery after balloon angioplasty. Biochim Biophys Acta, 2000; 1500: 41-48
52. Chen A, Mumick S, Zhang C, Lamb J, Dai H, Weingarth D, Mudgett J, Chen H, MacNeil DJ, Reitman ML, Qian S: Diet induction of monocyte chemoattractant protein-1 and its impact on obesity. Obes Res, 2005; 13: 1311-1320